Promoting Excellence in Diabetes Care

ADATS 2022
SPEAKERS & PROGRAM

MEET OUR ADATS 2022 SPEAKERS

Ted Wu
Dr Ted Wu

Time: 10:00-10:20
Topic: Type 2 and therapeutics – whats new and what’s coming

A/Prof John Wentworth

Time: 10:20-10:40
Topic: Type 1 prevention and therapeutics – what’s new and what’s coming

McAuley-Sybil
Dr Sybil McAuley

Time: 10:40-11:00
Topic: Automated insulin delivery – what’s new?

Cheryl Steele

Time: 11:00-11:20
Topic: Live Long and Prosper. Diabetes Tech into the future

Nuala Harkin

Time: 1:00-1:20
Topic: Continuous Glucose Monitoring in children and young adults – the lived Experience

Michelle Robins

Time: 1:20-1:40
Topic: Onboarding of diabetes technology – one size fits nobody

Glynis Ross
A/Prof Glynis Ross

Time: 1:40-2:00
Topic: CGM for type 1 diabetes across the lifespan, including diabetes (and aged care)

Dr Benjamin Sly
Dr Ben Sly

Time: 3:00-3:20-13:45
Topic:  Machine learning and electronic medical records for inpatient diabetes care

Laura Zimmerman

Time: 3:20-3:40
Topic: Rapidly evolving technologies – what should we consider in keeping our workforce upskilled? .

Renza Scibilia​

Time: 3:40-4:00
Topic: How do people with diabetes navigate healthcare in a digitally connected world?

Nyaree Lawler
Nyaree Lawler

Time: 4:20-4:30
Topic:  How SMART can we be? Delivering face-to-face programs online.

Prof Tim Jones

Time: 4:30-4:40
Topic: Accelerating the Implementation of new therapies in Type 1 Diabetes

22974
Dr Neil McMillan

Time: 4:40-4:50
Topic: Virtual Reality training to improve telemedicine delivery for diabetes-related foot complications

DavidONeal
Professor David O'Neal

Time: 15:25-15:50
Topic: Increasing Time in Range in adult populations

Dr Lori Laffel

Time: 15:50-16:15
Topic: Increasing Time in Range in paediatric populations

Add Your Heading Text Here

ADATS 2022 PROGRAM

Add Your Heading Text Here

Click here to download the program.

Add Your Heading Text Here

Add Your Heading Text Here

DR TED WU

Type 2 and therapeutics - whats new and what's coming

Biography

Dr Ted Wu is a senior staff specialist endocrinologist and the Director of the Diabetes Centre at The Royal Prince Alfred Hospital in Sydney, Australia, a visiting endocrinologist at Dubbo Base Hospital and an Honorary Professor at the Shijiazhuang Diabetes Hospital in Hebei, China as well as clinical diabetes, he has had a long-term interest in both teaching and research, focused on novel diabetes therapies, type 2 diabetes in young adults and diabetes complications.

He has published numerous articles, abstracts and book chapters and is a frequent invited speaker to international symposia.

He has been instrumental in establishing the Royal Prince Alfred Diabetes Centre as an International Diabetes Federation “Centre of Education” and National Association of Diabetes Centres “Centre of Excellence”.

SESSION DESCRIPTION

The last decade has seen a rapid acceleration in the introduction of new treatments for Type 2 diabetes.

However, the field is certainly not standing still, and many new and exciting developments are just beyond the horizon. This talk will focus on new medications and approaches in the management of Type 2 diabetes.

DR SYBIL MCAULEY

Automated insulin delivery – what’s new?

Biography

Dr Sybil McAuley is an endocrinologist at St Vincent’s Hospital Melbourne and a clinical researcher at the University of Melbourne. After studying medicine in Melbourne, Sybil worked as a junior doctor in Darwin, the Kimberley, Fremantle, and Sydney, before completing her endocrinology training back in Melbourne.

Her PhD investigating type 1 diabetes technology and exercise was awarded the prestigious TJ Martin Medal in 2018. Findings from her research have been incorporated into diabetes clinical practice guidelines for insulin pumps and for diabetes management around exercise.

Sybil now leads a diabetes clinical research program focussing on diabetes therapeutic technology, including insulin pump therapy, exercise, sleep, psychosocial well-being, and advancement of automated insulin delivery. She is passionate about integrating diabetes technology research and education with delivery of clinical care embracing technology.

SESSION DESCRIPTION

Since the first commercial hybrid closed-loop system was introduced into Australia in 2019, an increasing number of people with type 1 diabetes are using automated insulin delivery systems. Glucose benefits and safety have been demonstrated across broad population groups in clinical trials, and real-world evidence is rapidly emerging.

With three different automated insulin delivery systems currently marketed in Australia, users need to be supported to make informed and appropriate therapeutic choices, and to be educated regarding system use. Expectation management regarding clinical outcomes, as well as the limitations of current technology, is paramount.

This session will explore the evidence behind automated insulin delivery, populations the benefits relate to, and impact beyond glucose. What’s new in automated insulin delivery… heaps!

CHERYL STEELE

Live Long and Prosper. Diabetes Tech into the future

Biography

Cheryl is a Registered Nurse with post graduate qualifications in Midwifery, Health Counselling and Diabetes Education. She is the manager of Diabetes Education Services at Western Health.

Her primary interests in diabetes education are insulin pumps, Continuous Glucose Monitoring Systems and Diabetes in Pregnancy. Cheryl has co-authored papers in peer reviewed journals on Type 1 diabetes and Gestational Diabetes. As well as her clinical role Cheryl has a strong focus on Health Professional education for nurses, allied health, medical practitioners and students.

Cheryl is a member of the clinical advisory committee for Diabetes Victoria. Cheryl lives with Type 1 diabetes which she manages with a the Ypsopump and CAM APS FX after swapping from her DIY loop system.

SESSION DESCRIPTION

Live Long and Prosper. Diabetes Tech into the future. This presentation will explore what is on the horizon for diabetes technology.

NUALA HARKIN

CGM - what can we learn from our youth and apply to adults

Biography

Nuala Harkin is a Registered Sick Children’s Nurse, Registered General Nurse, Credentialled Diabetes Nurse Educator. Nuala’s background is in Paediatric Intensive Care Nursing, and she moved into the area of paediatric/adolescent diabetes in January 2000.

Nuala was the First Nurse Practitioner in the area of Paediatric and Adolescent Diabetes in Australia, becoming authorised in August 2004, and working in a full time position at the Children’s Hospital Westmead.

She has been involved in research, been co-author on a number publications, completed book reviews, and has presented her research at both national and international level. She is also passionate about her humanitarian work, and over a 5 year period has been involved in strengthening the healthcare systems at the Children’s Hospitals in Vietnam, to provide comprehensive diabetes education and care for children with Diabetes.

Nuala is also a Past President of the Australian Diabetes Educators Association.

SESSION DESCRIPTION

Continuous Glucose Monitoring in children and young adults the lived Experience.

MICHELLE ROBINS

Onboarding of diabetes technology - one size fits nobody

Biography

Michelle Robins has been working as a Credentialled Diabetes Educator since 1993 and endorsed Nurse Practitioner for 15 years. She is currently employed at Northern Health in Melbourne.

She has worked on 60 diabetes-related committees and working parties. Michelle has produced book chapters, presented at national and international conferences, at more than 160 workshops and more recently webinars and podcasts.

Michelle was the recipient of the Jan Baldwin Award 2010 and ADEA Honorary Life Member Award 2013.

Her mantra: education (for people with diabetes and health care professionals), is not about telling people what to do but why.

SESSION DESCRIPTION

Onboarding of diabetes technology – one size fits nobody We run the risk of educating people about technology by using a template only and reducing them to downloads, rather than the person-centred approach.

A/PROF GLYNIS ROSS

CGM for type 1 diabetes across the lifespan, including diabetes (and aged care)

Biography

Associate Professor Glynis Ross Associate Professor Glynis Ross is a Visiting Endocrinologist at Royal Prince Alfred Hospital, a Senior Staff Specialist at Bankstown-Lidcombe Hospital, and does regular outreach work in Central West NSW. Since 2016 she has been a Director on the Board of Diabetes Australia. Glynis has been the Lead Endocrinologist of the Diabetes and Pregnancy service at RPAH for over 30 years. Glynis was on the Australian Diabetes Society Council from 2012-2020 and is the immediate Past President. She was on the Australasian Diabetes in Pregnancy Society (ADIPS) Council for 2 x 8 year terms and was President 2008-2010.

Since 2013 she has chaired the NDSS Diabetes in Pregnancy Expert Reference Group and from 2004 has been a member of the national Diabetes Expert Advisory Group. Glynis is currently Chair of the ADS Education Advisory Council. In addition she is Chair of the NDSS Diabetes Expert Reference Group, a member of the NSW Diabetes and Endocrine Executive, national Diabetes Expert Advisory Group and involved in the National Diabetes Strategy.

Her major clinical and research interests are diabetes in pregnancy, type 1 diabetes, insulin pump therapy and inpatient diabetes management. She serves on a variety of other state and national working parties and in teaching programs for trainees in anaesthetics, obstetrics & gynaecology, physicians, midwives, general practitioners and medical undergraduates.

SESSION DESCRIPTION

Continuous glucose monitoring (CGM) systems have been shown to be of great value for people living with type 1 diabetes of all ages.

There are clinical benefits for personal glycaemic management, confidence building and quality of life for those living with type 1 diabetes across all ages. There are potential benefits for their support network and direct carers. CGM data can guide better-informed management decisions by diabetes health professionals.

Until recently in Australia the cost burden has greatly limited use. However this has not been the only barrier to uptake and ongoing use of CGM so it is important to consider and understand other barriers to CGM use which may vary at different stages of life and need to be addressed.

DR BEN SLY

Machine learning and electronic medical records for inpatient diabetes care

Biography

Dr Sly is an Endocrinologist at the Princess Alexandra Hospital in Brisbane.

He is the chair of the Queensland Health Digital Diabetes Working Group and a PhD candidate at the University of Queensland Centre for Health Services Research investigating the management of diabetes for patients in a digital hospital system.

SESSION DESCRIPTION

Dr Sly will discuss the management of patients with diabetes in a digital hospital system and the potential role of machine learning interventions.

LAURA ZIMMERMAN

Rapidly evolving technologies – what should we consider in keeping our workforce upskilled?

Biography

Laura is an innovative clinician with 14+ years’ experience chronic disease management and systems development. Having established a highly successful private Diabetes Specialty practice across QLD and NSW, and throughout Australia via telehealth. She is an expert in the education and management of patients across the full spectrum of diabetes, including insulin pumps and continuous glucose monitoring (CGM).

SESSION DESCRIPTION

TBA

RENZA SCIBILIA

How do people with diabetes navigate healthcare in a digitally connected world?

Biography

Renza Scibilia has lived with type 1 diabetes since 1998. She is a diabetes advocate and activist, and is the Head of Communities and International Affairs at Diabetes Australia. She has worked for diabetes organisations for the last twenty years, promoting a person-centred approach to the development, design and delivery of diabetes technologies, services, resources, research and education programs. She is a spokesperson for the organisation and endeavours to ensure the lived experience narrative is centred in diabetes discussions.

Renza has recently been appointed Global Head of Advocacy for #dedoc, a European-based profit for purpose organisation which provides opportunities for diabetes advocates from across the world to become part of a peer network and attend professional conferences under the banner #NothingAboutUsWithoutUs.

Since August 2017, Renza has been wearing a DIYAPS, which automates insulin delivery, and she is part of the #WeAreNotWaiting movement.

Renza has extensive experience as a consultant, facilitator, presenter, and media spokesperson and is frequently invited to speak at conferences where she speaks about topics including peer support in diabetes management, diabetes technology, and why communication matters in diabetes and healthcare. Renza is well-known in the diabetes online community, and is well-versed in social media, its use and impact on people with chronic health conditions and application in peer support. She is the author of Diabetogenic, (www.diabetogenic.wordpress.com) and a regular contributor to many online and print health publications.

SESSION DESCRIPTION

People with diabetes have the opportunity to access and use digital tools for their own diabetes management and connecting with their healthcare team.

How are we doing that in a safe, empowering and pioneering way?

NYAREE LAWLER

How SMART can we be? Delivering face-to-face programs online

Biography

Her role as a Credentialled Diabetes Educator over the last 19years has been in various Primary Health and Community Health sectors throughout Western Australia. Currently his main role is working at Diabetes WA but he still works in the Wheatbelt region of WA for the Wheatbelt Aboriginal Health Service, as well as in private practice.

She has a passion for providing services to people in regional areas, both face to face and through the use of technology.

Her role at Diabetes WA includes providing group sessions such as OzDAFNE, DESMOND and the SMARTs programs, as well individual services through our Telehealth service and Helpline. She also facilitates online programs, webinars and virtual programs.

SESSION DESCRIPTION

Diabetes WA SMARTs programs are person-centred, topic specific, face-to-face diabetes group education programs, underpinned by Social Cognitive Theory.

Like many other programs during Covid-19, these services were cancelled. So, Diabetes WA set out to translate the face-to-face programs into virtual programs that continued to promote the interactivity and skills mastery opportunities that participants would usually experience in the face-to-face programs.

PROF TIM JONES

Accelerating the Implementation of new therapies in Type 1 Diabetes

Biography

Professor Tim Jones completed his paediatric training in Australia and in the UK, and post-doctoral training at Yale University, USA. Professor Jones is a clinician researcher and despite being a full-time hospital clinician for most of his career, he has established an international reputation in the field of paediatric diabetes with a strong clinical research interest, particularly in quality data collection, hypoglycaemia, insulin therapy, exercise, technology and complications.

Professor Jones also leads a number of national trials, in particular hybrid closed loop trials and more recently Co-directs the JDRF Global Centre of Research Excellence which is an international collaboration aimed to accelerate translation of new therapies and models of care in Type 1 Diabetes. Professor Jones is the Director of Research at the Perth Children’s Hospital (PCH) for the Child and Adolescent Health Service and a Consultant in the Diabetes and Endocrinology Department. Professor Jones co-leads the Children’s Diabetes Centre, based at the Telethon Kids Institute and Perth Children’s Hospital, an integrated clinical and research centre established in 2015 by a Centre for Research Excellence grant from the National Health and Medical Research Council (NHMRC) and the JDRF.

SESSION DESCRIPTION

The JDRF Global Centre of Excellence will develop frameworks and approaches to accelerate innovations into clinical practice.

This will involve determining the broad costs and benefits of treatments and trialling new care models.

DR NEIL MCMILLAN

Virtual Reality training to improve telemedicine delivery for diabetes-related foot complications

Biography

Hi is a Principal Medical Scientist for Vascular Surgery (The Queen Elizabeth Hospital) and an Affiliate Senior Fellow with the University of Adelaide. He was previously a Senior Research Development Officer with the Faculty of Health and Medical Sciences.

He leveraged his background in psychological science to coordinate a variety of clinical research, with expertise in data and research management, grant writing, strategic analysis, and professional development. He researches novel technologies and organise large, multi-centre data registries and outcome studies in assessment and monitoring of diabetes-related foot complications and lower limb ischaemia, as part of the Vascular Surgery Research Group .

Their research program is designed to address the many multi-disciplinary gaps in patient care for this cohort. Projects include: – creation and testing of Virtual Reality training modules for community care workers to help in managing diabetes-related foot disease in Aboriginal people – blood and tissue biobanking and patient registries for cardiovascular disease and lower-limb complications – patient-centered outcomes in chronic limb-threatening ischaemia Until recently, he was a research fellow and laboratory coordinator in psychology studying animal behaviour and cognition across a range of topics.

He completed his Honours degree at Wilfrid Laurier University and his MSc and PhD at the University of Western Ontario (as NSERC Canada Graduate Scholar), as well as a Postdoctoral Fellowship at the University of Alberta (all in Canada).

SESSION DESCRIPTION

Diabetes-related foot complications are the chief cause of amputation in Australia (5,200 per year); best-practice, multi-disciplinary care reduces rates by around 50%. However, access to multi-disciplinary case is difficult in rural and remote locations, which in part drives disproportionate morbidity among people living outside cities. Telehealth can help bridge the gap in specialist care, but involving rural generalists vastly improves care and engagement.

We have designed a Virtual Reality clinic environment and case study for training clinicians in assessing and triaging diabetes-related foot complications, specifically designed to be relevant and culturally appropriate for Aboriginal people. We are currently testing this program at community sites around South Australia.